ProShares - UltraShort Health Care

ProShares - UltraShort Health Care

RXD
ProShares - UltraShort Health CareUS flagNew York Stock Exchange Arca
- -
USD
- -
- -
No data availableFinancial data will appear here once available

Capital Structure

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Working Capital

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Growth Rates

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Revenue

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Earnings Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Quarterly Dividends Per Share

FRC

in mil. unless spec.
No data availableFinancial data will appear here once available

Company Description

APIChat
Sector
Financial Services
Industry
Asset Management - Leveraged
Address
7501 Wisconsin Avenue, Suite 1000E Bethesda MD United States of America 20814
IPO Date
Feb 1, 2007
Business
ProShares UltraShort Health Care (RXD) is an exchange-traded fund managed by ProShare Advisors LLC that seeks daily investment results, before fees and expenses, corresponding to two times the inverse (-2x) of the daily performance of the S&P Health Care Select Sector Index. The fund invests principally in derivatives such as swap agreements with major global financial institutions including UBS AG, Citibank NA, Goldman Sachs International, Bank of America NA, BNP Paribas, and Societe Generale to achieve its inverse leveraged exposure; it also holds money market instruments like U.S. Treasury bills and repurchase agreements for cash balances. Launched on January 30, 2007, and listed on NYSE Arca with CUSIP 74347G564, the fund has a net expense ratio of 0.95% after contractual waivers through September 30, 2026, quarterly distributions, and options availability. The S&P Health Care Select Sector Index tracks health care companies from the S&P 500 in industries including health care equipment and supplies, health care providers and services, health care technology, biotechnology, pharmaceuticals, and life sciences tools and services; these are weighted by market capitalization with rebalancing every September and adjustments in March, June, and December. RXD targets sophisticated investors seeking short-term bearish exposure to the U.S. health care sector, with daily rebalancing to maintain -2x leverage, though longer holding periods may result in returns deviating significantly from the daily target due to compounding, volatility, and leverage effects. The fund operates in the U.S. market, with ProShare Advisors headquartered in Bethesda, Maryland. Recent developments for ProShares include the launch of leveraged ETFs such as the ProShares Ultra Solana ETF (SLON) and ProShares Ultra XRP ETF (UXRP) in July 2025, expanding its crypto-linked offerings with 2x daily returns via futures contracts following NYSE Arca approval; additionally, a suite of dynamic buffer ETFs was introduced in June 2025 using a patent-pending volatility-adapting methodology for U.S. stock indexes. In September 2025, ProShares strengthened its distribution capabilities by hiring three Regional Vice Presidents: Chad Brand, Mike Hart, and Matt Zorumski. RXD itself continues quarterly distributions, with an ex-dividend date of December 23, 2024, at $0.10129 per share, and maintains its fee waiver structure as of the September 26, 2025 prospectus.